Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jianfang Jin Insider Profile
4 Followers
Jianfang Jin, Chief Executive Officer, Ten Percent Owner at Genix Pharmaceuticals, holds 6.32M shares in Genix Pharmaceuticals (Ticker: TSE:GENX). Most recently, Jianfang Jin Bought C$2,250,000 shares of Genix Pharmaceuticals on Apr 20, 2015 for an estimated value of 112.50K.
Jianfang Jin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Executive Officer, Ten Percent Owner
Roles that Jianfang Jin holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jianfang Jin
Jianfang Jin's Trading History
List of latest transactions for each holding click on a transaction to see Jianfang Jin's performance on stock
You May Also Like
Jianfang Jin insider profile FAQ
What is the percentage of profitable transactions made by Jianfang Jin?
The percentage of profitable transactions made by Jianfang Jin is ―.
What is the average return per transaction made by Jianfang Jin?
The average return per transaction made by Jianfang Jin is ―.
What stocks does Jianfang Jin hold?
Jianfang Jin holds: TSE:GENX stocks.
What was Jianfang Jin’s latest transaction?
Jianfang Jin latest transaction was an Informative Buy of C$112.50K.
What was Jianfang Jin's most profitable transaction?
Jianfang Jin’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jianfang Jin's role in Genix Pharmaceuticals?
Jianfang Jin's role in Genix Pharmaceuticals is Chief Executive Officer, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.